Stephen Baylin
11 results.
Cancer cells are masters of disguise.
Like villains in bad movies, they evade detection by masquerading as healthy cells, turning off the body’s built-in alarm…
GRAND RAPIDS, Mich. (Dec. 9, 2024) — A trio of esteemed scientists from Van Andel Institute and Johns Hopkins University will receive the Harvey Prize for their…
Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…
GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…
Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer
The Coriell Institute for Medical Research and…
Four years ago, we embarked on a collaborative endeavor to improve cancer treatment by establishing the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics…
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers
By Dr. Peter Jones and Dr. Steve Baylin
…